Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2014, OTV is a venture capital fund with offices in New York and Tel Aviv. The firm specializes in mid-growth stage investments, focusing on digital health startups that aim to make a significant impact on healthcare. OTV manages a portfolio of nine companies and actively seeks to support entrepreneurs addressing real-world healthcare challenges.
OTV invests in mid to growth stage startups within the digital health sector, primarily targeting Series A and Series B companies. They look for entrepreneurs with viable business models and innovative solutions that address pressing healthcare issues. The firm emphasizes game-changing innovations that can transform the healthcare landscape.
Notable portfolio companies include mPharma, which focuses on making medicine accessible and affordable, and Atrica, a mobile infrastructure platform acquired by Nokia. Other significant exits include CFR Pharmaceuticals (acquired by Abbott), Dynamic Yield (acquired by McDonald's), and Nutranext (acquired by Clorox).
Submit through their form at this link.
OTV often leads investment rounds, particularly in Series A and B stages, where they can provide substantial support to portfolio companies.
OTV is open to follow-on investments in their portfolio companies, especially if the startups demonstrate continued growth and innovation.
OTV's current fund size is not publicly disclosed, but they focus on significant investments in mid to growth stage startups.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.